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Abstract
Background: In Shanghai there are 1.2 million people with hypertension, many of whom have difficulty
in affording medical treatment. Community based, anti-hypertensive clubs have been created to provide
health education but education alone is often ineffective. Lifestyle change programmes have shown some
potential for reducing blood pressure but in previous trials have required specialist staff and extensive
contact. We have previously demonstrated that self-management programmes delivered by health
professionals, such as a nurse who has had short training in self-management techniques can change health
behaviour and reduce symptoms. This study was designed to evaluate the benefits of a simple, cognitive-
behavioural, self-management programme for hypertension based around a hypertension manual and
delivered in the setting of a community anti-hypertensive club in Shanghai.
Method: The method was a pragmatic randomised controlled trial with an intention-to-treat analysis.
Adult patients with mild-to-moderate primary hypertension, waiting to join a neighbourhood anti-
hypertension club, were randomised to the self-management programme or to an information only
control procedure. They attended the group treatment sessions on 4 occasions over 5 weeks for
education combined with goal setting for lifestyle change and an introduction to exercise. The main
outcome measures were: changes in blood pressure; blood total cholesterol; diet; activity level and health
related quality of life 1 month and 4 months after the end of treatment.
Results: A total of 140 adults with mild-to-moderate primary hypertension took part. All of the main
outcomes showed beneficial changes. Four months after the end of treatment the mean blood pressure
differences between groups were systolic 10.15 mm Hg (P < 0.001, 95% CI 7.25–13.05), and diastolic 8.29
mmHg (P < 0.001, 95% CI 6.71–9.88). Patients in the intervention group also had significantly reduced
weight, lowered blood total cholesterol, increased physical activity and improved quality of life.
Conclusion: Patients with mild-to-moderate primary hypertension attending a 5 week, group and manual
based, cognitive-behavioural self-management programme, delivered through a voluntary club in Shanghai
experienced a significant reduction in blood pressure.
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Background
Hypertension is associated with a number of health
behaviours such as lack of exercise and an unhealthy diet.
Trials of lifestyle change programmes have shown worth-
while improvements in blood pressure (BP). For example
the PREMIER trial, after subtracting change in the control
group, showed a net reduction of 3.7 mmHg (P < 0.001)
in systolic BP at 6 months and 4.3 mmHg (P < 0.001) in
a second group of patients having additional counselling
about an anti-hypertensive diet (the DASH diet) [1]. At 18
months the differences were not statistically significant
[2]. In the ADAPT trial in Australia, positive changes in
lifestyle and blood lipids were observed; however, the
study appeared not to have reported the effect of its inter-
vention on BP [3]. Both trials involved intensive contact
with patients, long-term follow up and multi-professional
input. For example, in the PREMIER trial patients
attended 18 group sessions over 6 months plus 4 individ-
ual training sessions. Some cognitive-behavioural studies
have targeted stress as a potential risk marker but results
from such programmes have been mixed. A study by
Linden [4] demonstrated that individualised stress man-
agement was associated with ambulatory BP reductions;
however some other studies, e.g. Johnston's [5], have
failed to replicate this effect. According to Mancia [6],
stress may be linked to hypertension through increasing
unhealthy behaviours. Reviewing these studies the 2004
Canadian recommendations for the management of
hypertension recommended its use only in selected indi-
viduals [7].
In Shanghai the prevalence of hypertension has been ris-
ing for almost two decades; in 1991 it was 13%, in 1998
17% and in 2001 19% [8]. In 2006, 29.8% of over-35s in
Shanghai were hypertensive [9]. The majority of Chinese
patients are unable, or unwilling, to pay for expensive
'western' medicines for hypertension. Instead many use
local cheap herbal medicines [10,11], for example the
zhenju pill, a compound of chrysanthemum, pearl and a
diuretic. There are believed to be 1.2 million hypertensive
people in Shanghai [8]. As they get older there is likely to
be an increase in the number of strokes and heart disease
which will have a profound effect on the health of the
population. In response a community based chronic dis-
ease management strategy has been adopted. One aspect
of this strategy has been the establishment of voluntary
and very popular 'hypertension and cardiac rehabilitation
clubs'. Patients who join the clubs have public lectures on
hypertension and lifestyle change with 40 or 50 people
attending each time.
Educational interventions are known to be a relatively
weak method for behavioural change when compared
with cognitive-behavioural self-management pro-
grammes [12]. Unfortunately there are many patients to
treat and few health professionals trained in cognitive-
behavioural methods. One solution for delivering cogni-
tive-behavioural self-management programmes to large
numbers of people is the use of self-help manuals 'facili-
tated' by brief contacts with a health professional or lay
person who has had short training in the cognitive-behav-
ioural methods employed in the programme. Examples
include the Heart Manual for delivering post-MI (myocar-
dial infarction) cardiac rehabilitation which has been
evaluated in several trials versus both routine care [13]
and multi-disciplinary hospital based programmes [14]
and has been found to be superior to the former and equal
to the latter. In the UK the National Institute for Clinical
Excellence has recently recommended the Heart Manual
as being equivalent to a multi-disciplinary phase III hos-
pital based rehabilitation programme and it is being
widely used for that purpose. A similar self-management
programme, the Angina Plan reduced episodes of angina
by 40% and improved a number of health behaviours
when delivered through 4 brief contacts with a nurse [15]
and this too is being increasingly adopted across the UK.
In the study reported here we developed and evaluated a
5 week, group and manual based, cognitive-behavioural
self-management programme for hypertension that could
be delivered in the setting of a community based 'hyper-
tension and cardiac rehabilitation club' in Shanghai.
Methods
Study participants
The study was conducted in a community anti-hyperten-
sive club in Tilanqiao Neighbourhood, Shanghai. A
chronic disease management system had been established
in this neighbourhood as part of the work of the Tilanqiao
Community Health Services Centre (CHSC). In this sys-
tem all patients with a chronic disease receive regular
health checks, the frequency of these depending on the
severity of the illness. The checks are administered by
community 'doctors' who are health workers trained in
public health but have no right to prescribe medicine. For
hypertensive patients, community doctors go to their
homes at regular intervals to measure blood pressure and
give simple advice about managing the disease.
The research subjects were adults with mild-to-moderate
primary hypertension with no evidence of serious co-mor-
bidity such as diabetes and angina. According to the 2003
European Society of Hypertension guidelines for the man-
agement of arterial hypertension [16], such patients need
to be monitored for at least 3 months with only non-phar-
macological treatment rather than begin drug treatment
promptly. Hypertensive patients with concomitant diabe-
tes, even if they have only high normal BP, are classified
as at high risk, and should initiate immediate anti-hyper-
tensive drug treatment which would have confounded theBMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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results of the trial. We had intended to recruit patients not
having started drug therapy; however this was not availa-
ble in the system, as all patients had been on medication,
although the majority were taking herbal medicine. Fur-
thermore, under the chronic disease management system
in force in this neighbourhood diabetic patients were part
of a different monitoring mechanism. Therefore diabetic
patients were not included in the trial.
The inclusion criteria were:
• clinician diagnosed mild-to-moderate primary hyper-
tension defined as having systolic BP between 140 and
180 mm Hg and/or diastolic BP between 90 and 110
mmHg in accordance with patients' medical records;
• patients aged 18–69 years: this was because the physical
activity questionnaire we used was only valid in this
range.
The exclusion criteria were:
• secondary forms of hypertension (e.g. hypertension
resulting from renal disease);
• target organ damage and/or diabetes;
• congestive heart failure;
• angina;
• other life-threatening co-morbidity (e.g. carcinoma, ter-
minal liver or renal failure);
• disability that would prevent participation in a walking
exercise regime;
• an inability to read or communicate in Chinese and/or
a history of reduced cognitive ability.
Recruitment and randomisation
The names of the patients who satisfied the entry criteria
were taken in a serial fashion from the list of patients
being actively followed up in the chronic disease manage-
ment system. The principle investigator (FX), accompany-
ing a community doctor, conducted home visits and
explained the study to these patients. If interested in tak-
ing part, they were given an information sheet and con-
tacted again by telephone after one week. If still willing to
take part, they were then invited to the CHSC for a base-
line assessment. Informed consent was obtained, follow-
ing which they were randomised by an independent
community health doctor who was not involved in the
research in any other way. The research subjects automat-
ically became members of the Tilanqiao Community
Anti-Hypertensive Club.
The patients were randomised to either the self-manage-
ment programme or an information only control group
with the promise that they would receive the intervention
once the study was completed. Randomisation codes were
generated by STATA and the person who executed the
allocation sequence was blinded to the patients and took
no other part in the research.
The intervention
The self-management group intervention was delivered in 4
small group sessions spread over 5 weeks, the final session
taking place two weeks after the third session. Each small
group comprised 10–12 patients, there being 6 groups in
all. Each of the first three sessions lasted 2.5 hours, and
the final session around 1 hour. Table 1 presents the con-
tent of each session.
The programme followed a common format, consisting
of:
• An educational talk, in accordance with a self-manage-
ment manual (the Hypertension Manual), from a com-
munity doctor who was trained by the principal
investigator (FX) in the methods being used in the pro-
gramme. The community doctor also led three group exer-
cises, which were, respectively, using digital BP meter,
calculating body mass index (BMI), and estimating food
energy.
Table 1: contents of the cognitive-behavioural self management programme for hypertension by session
Day 1 in Week 1 (9.00–11.30) Day 2 in Week 2 (9.00–11.30) Day 3 in Week 3 (9.00–11.30) Day 4 in Week 5 (9.00–10.00)
• Basic knowledge of hypertension • Feedback from practice of goals • Feedback from previous goals • Feedback from previous goals
• Introduction to goal setting • Physical activity, DASH diet, salt, 
alcohol, smoking
• Managing the pills • Patient led exercise session
• Group exercise – using digital BP 
meter
• Patient led exercise session • Patient led exercise session • Maintaining change
• Handing out booklets 2–5 • Group exercise – calculating BMI • Group exercise – food energy 
calculation
• Setting new goals
• Setting initial goals • Setting new goals • Setting new goalsBMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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• Goal setting for behaviours that would reduce hyperten-
sion such as improved diet or a higher level of activity.
From the second session onwards patients reported back
to their group the progress they had made with their indi-
vidually set goals and received praise and encouragement
from the group members before setting further goals.
Between each session every patient was contacted by a
'group facilitator' (one of the group members) who
phoned the others to check progress with the 'homework'
goals that the patient had set in the group session. This
facilitator was chosen by the principle investigator (FX)
using his subjective judgement as to which patient would
be most suitable for this role.
• A patient led exercise session. In each group one patient
volunteered to give demonstration and then lead an exer-
cise session in a form of exercise they knew well; in most
cases this was tai chi or fan dance.
Self-monitoring was known to improve health behaviour
and patients were provided free of charge with a digital BP
meter, a weight scale, and a measuring tape to record daily
BP, as well as weekly weight and waist circumference.
Patients were given a copy of the Hypertension Manual,
which consisted of 5 separate booklets handed out at the
first session.
• Booklet 1 gave basic knowledge about the causes of
hypertension and dealt with a number of common mis-
conceptions about hypertension. It also explained goal
setting techniques and the self-monitoring of BP using the
equipment provided.
• Booklet 2 gave information about desirable lifestyle
changes including smoking cessation, increased levels of
activity, weight reduction, controlling alcohol consump-
tion to moderate levels, reducing the use of dietary
sodium, and details of the DASH eating plan that was pre-
viously shown to reduce BP.
• Booklet 3 concerned compliance with medication and
the maintenance of behaviour change.
• Booklet 4 was a diary for recording their daily BP as well
as weekly weight and waist circumference.
• Booklet 5 was the 'Action Plan', a set of goal sheets on
which the patients set out and recorded their success with
their weekly goals.
The text of these booklets is available in both English and
Chinese from the principal investigator (FX).
The main hypothesised therapeutic components of the
intervention were: increasing activity levels, a reduction in
or cessation of smoking, reduced sodium consumption
and improved diet.
The main therapeutic methods employed were: education
about the illness and changing unhelpful misconceptions,
goal setting, group facilitation, self-monitoring and self-
recording.
The control group received a booklet that was given to all
members of the anti-hypertension clubs explaining desir-
able behavioural change and giving important informa-
tion about hypertension. At the completion of the study
the control group also took part in the self-management
programme.
Both groups also received usual care as part of the chronic
disease management programme.
Sample size
The following assumptions were made: that the standard
deviation of diastolic BP was 10 mmHg [17] and a reduc-
tion of blood pressure by 10/5 mmHg would be a clini-
cally significant improvement [18]. Previous research
showed that the DASH eating plan could lead to a reduc-
tion in diastolic pressure of 5.5 mmHg [19] and a reduc-
tion of 5–10% of body weight could reduce systolic and
diastolic blood pressure by between 4–7 and 3–6 mm Hg
respectively [20]. It was therefore thought reasonable to
predict a mean diastolic blood pressure reduction of 5
mm Hg might be achieved. Requiring 80% power to
detect such a change at α = 0.05 level would require 126
patients (63 in each group). Allowing for an attrition rate
of 10% of patients over the course of the study yielded a
recruitment target of 70 patients for each arm of the trial.
Outcome measures
Baseline data was collected during the initial screening
visit. Follow up data was collected on 2 occasions after
treatment, the 1 st follow-up being 1 month after the end
of treatment and the 2nd follow up being 4 months after
the end of treatment. Staff blind to randomization col-
lected and scored all measurements.
Blood pressure measurements were obtained by trained, cer-
tified individuals who used a mercury sphygmomanome-
ter. After the participant sat quietly for 5 minutes, the
observer measured BP in the right arm with an appropri-
ately sized cuff. At each visit, 2 BP measurements sepa-
rated by at least 30 seconds were obtained. A reading of
systolic BP was taken when the first Korotkoff sound
appeared, and a reading of diastolic BP was taken when
the Korotkoff sounds disappeared [21]. At each assess-BMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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ment point, BP was the mean of all available measure-
ments.
Weight, height and waist circumference were measured
using, respectively, a calibrated scale, a wall-mounted sta-
diometer and an inelastic tape maintained in a horizontal
plane.
Biochemical tests were taken by a chief technician and ana-
lysed at a laboratory in a hospital that was not connected
to the study in any other way. Urine sodium and potas-
sium was measured using ion selective electrodes (ISE);
and the cholesterol oxidase method was used to establish
blood total cholesterol. The normal range for blood total
cholesterol was 2.8–5.8 mmol/L; for urine sodium 130–
260 mmol/24 h; for urine potassium 25–100 mmol/24 h.
Urine sodium divided by potassium was equal to the
urine sodium-to-potassium (Na/K) ratio.
Risk markers – physical activity, diet, smoking, drinking
Information about physical activity was collected using
the international physical activity questionnaire (IPAQ)
[22]. Data collected with the IPAQ was reported as a con-
tinuous measure. The volume of activity was computed by
weighting each type of activity according to its energy
requirements to yield a score in MET-minutes. Total Phys-
ical Activity MET-minutes/week was equal to the sum of
Walking, Moderate and Vigorous MET-minutes/week
scores. The IPAQ instruments had been validated in
China [23]. Diet was assessed using a validated dietary
questionnaire [24] asking about intake of food items in
the last three months, based on which the daily intake of
food groups (red meat, vegetables, fruits) was calculated.
For smoking, we asked patients if they had smoked in the
last 4 weeks. For drinking, we asked them if they had: (1)
1–4 drinks per week; (2) more than 5 drinks per week.
Health Related Quality of Life (HRQOL)
Quality of life was assessed using the Medical Outcomes
Study Short Form 12 Health Survey (SF12), a widely used
tool to measure quality of life. SF-12 was derived in the
United States from the twelve questions of the SF-36. It
provides scores in two domains: the Mental Component
Summary (MCS) and Physical Component Summary
(PCS) scales [25]. Possible scores range from 0 to 100 with
higher scores indicating better quality of life.
Statistical Analysis
An intention-to treat analysis was used with missing final
scores being replaced with the last valid observation for
that subject. Use of the last observation carried forward is
a popular and simple practice in analysing clinical trial
outcomes [26]. Variation in outcome between the six sub-
groups was tested by analysis of covariance (ANCOVA)
within the intervention group only adjusting for baseline
as well as for subgroup as a categorical factor. This was
only significant in one (P < 0.05) out of the 26 analyses,
suggesting that subgroup effects were not important, and
it was therefore justifiable to use simple ANCOVA as a sta-
tistical method for removing the effect of the baseline var-
iable in testing for intervention effects. Comparison of
groups for changes in smoking and drinking were made
using chi-squared tests. When making comparisons
between the intervention and control groups, adjusted
means were used. All statistical tests were two-tailed and
had a significant level of 5% (α = 0.05).
The use of effective western medication was uncommon
but many patients took herbal remedies, the effectiveness
of which was unknown. To control for the possibility that
any change in blood pressure outcomes observed were the
result of changes in the extent of the use of medications, a
categorical variable called 'drug use' was created to ascer-
tain if there were systematic changes in the use of these
medications at the 2nd follow up assessment. Three out-
comes were categorised; these were: 'patient reducing the
dose', 'patient increasing the dose' and 'no change'. With
blood pressure used as the dependent variable, baseline
blood pressure as the covariate, and the variable 'drug use'
as the fixed factor, we examined if a change in the use of
medications between groups resulted in the change in
blood pressure.
All statistical analyses were executed using SPSS 14.0 for
Windows.
Ethical approval
This trial was carried out as part of the doctoral research
training programme at the Department of Health Sciences
of the University of York, United Kingdom. All student
research must be approved by the Research Governance
Committee at the University of York. The Centre for Dis-
ease Control in Hong Kou district Shanghai also reviewed
and approved the protocol.
Results
Baseline characteristics
Recruitment began in November 2004 and ended in May
2005. The participant flow during the trial is shown in Fig-
ure 1:
Randomisation was successful and there were no signifi-
cant differences between groups in any of the baseline
measures (Table 2). In the intervention group, 53 (75.7%)
people claimed they had obtained knowledge about
hypertension in the past six months; and in the control
group 58 (82.9%) people. There were only 24 smokers
among the participants, 11 (15.7%) in the intervention
group and 13 (18.6%) in the control group; and there
were 28 drinkers, 17 (24.3%) in the intervention groupBMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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and 11 (15.7%) in the control group. In the intervention
group, 10 (14.3%) had more than 5 drinks per week; and
in the control group, 5 (7.1%). All the participants had
been taking medications and the majority (72.9%) were
taking the zhenju pill. The numbers taking western drugs
in the intervention and control groups were, respectively,
32 and 24; and the difference was not statistically signifi-
cant.
Intervention effects
The differences in outcomes for the two groups 1 month
and 4 months after the end of treatment are summarised
in Table 3.
Blood pressure
Table 3 and Figure 2,3 present the differences between
groups in blood pressure at both follow-up assessments.
The intervention, but not the control group, experienced
a significant reduction in both systolic and diastolic blood
pressure at both assessments.
Biochemical and clinical measures
Table 3 shows a similar pattern of findings for blood total
cholesterol, BMI and waist circumference. The variable of
urine Na/K ratio was not normally distributed. Logarith-
mic transformation was performed so that it could be ana-
participant flow Figure 1
participant flow.BMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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lyzed using ANCOVA which showed that the differences
were not significant.
Behavioural risk markers
The intervention group showed a much greater increase in
physical activity than the control group but no significant
differences existed between the two groups in dietary
behaviours. For smoking and drinking, neither showed a
significant difference in changes between the two groups.
There were 9 (13.2%) smokers in the intervention group
and 9 (14.3%) smokers in the control group 4 months
after the end of treatment. In the intervention group 1
patient had quit smoking, and 1 smoker had dropped out
of the study; in the control group 1 patient had quit smok-
ing, and 3 smokers had dropped out of the study. In the
intervention group 6 patients stopped having more than 5
Table 2: Baseline characteristics of participants by group
Intervention group (n = 70) Control group (n = 70)
Demographics
Gender Male (n) 29 (41.4%) 29 (41.4%)
Female (n) 41 (58.5%) 41 (58.5%)
Age a 57.5 (6.96) 57.4 (6.95)
Years after diagnosisb 7.50 (4.00,15.00) 8.50 (3.75,18.50)
Highest level of Education Junior middle school and below 29 (41.4%) 24 (34.3%)
Secondary technical school 8 (11.4%) 9 (12.9%)
Senior middle school 12 (17.1%) 19 (27.1%)
College (Associate) 14 (20.0%) 12 (17.1%)
University (Bachelor) 7 (10.0%) 6 (8.6%)
Monthly income (yuan) ≥10000 1 (1.4%) 0 (0)
5000–9000 3 (4.3%) 0 (0)
2000–4000 9 (12.9%) 4 (5.7%)
1000–2000 19 (27.1%) 31 (44.3%)
≤1000 38 (54.3%) 35 (50.0%)
Clinical indicators
BP (mm Hg) Systolic a 141.66 (12.81) 141.64 (12.65)
Diastolic a 89.70 (7.82) 89.43 (7.53)
Body mass index (BMI)a 25.17 (3.01) 24.74 (2.99)
Blood total cholesterola(mmol/L) 5.74 (1.01) 6.00 (1.28)
Urine Na/K ratiob 2.11 (1.34–3.09) 2.40 (1.39–3.77)
Waist circumferencea(cm) 85.87 (8.62) 83.61 (9.19)
Quality of life
HRQOL SF-12 Physical domain a 43.32 (7.59) 43.85 (7.53)
Mental domain a 51.87 (8.24) 53.49 (8.34)
Behavioural indicators
Physical activity Sitting total minutes/week a 1676.29 (931.44) 1703.36 (895.74)
Total physical activity a
(MET-minutes/week) 3753.86 (2480.79) 3916.44 (2471.21)
Diet Red meat (g) a 60.01 (37.96) 52.99 (31.09)
Vegetables (g) a 320.77 (95.44) 320.05 (93.97)
Fruits (g) a 154.26 (86.44) 164.99 (91.72)
Medications
Zhengju pill 43 59
Western medicine 32 24
aMean (SD)
b Median (25–75th percentile)BMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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drinks per week 4 months after the end of treatment, and
in the control group 1 patient.
HRQOL
The mean differences in quality of life scores as measured
by the physical and mental dimensions of the SF-12 were
statistically significant with the intervention group having
a clear advantage.
Exploring interaction of drugs with BP
ANCOVA showed that changes in taking anti-hyperten-
sive drugs could not explain the reduction of blood pres-
sure (for SBP, F = 1.68, P = 0.19; for DBP, F = 1.38, P =
0.26). More people in the intervention group had reduced
medication 4 months after the end of treatment, and the
differences were statistically significant (P = 0.02) (Table
4). Also, there were no significant differences between the
groups in the proportions taking western drugs at the end
either in those taking at the start, 27 (84%) in interven-
tion versus 19 (79%) in controls, or in those not taking at
the start, 1 (3%) versus 3 (6%). Furthermore, the differ-
ences between the groups in final blood pressure (both
SBP and DBP) remained at P < 0.001 even when one
adjusted for the changes in medication in a multiple
regression. Therefore the effect of the changes in use of
medication over the trial on blood pressure can be
excluded.
Discussion
This study indicates that, at least in the short term, a sim-
ple cognitive-behavioural self-management intervention
can lead to clinically significant reductions in both systo-
lic and diastolic blood pressure. Patients also reduced
their waist circumference, lost weight, became more active
and reduced their blood cholesterol. Although previous
trials of behavioural change programmes have produced
similar benefits for hypertensive patients [1-3] this trial
did so with a very much lower amount of input: only 8.5
hours of face to face contact and a simple self-help man-
ual.
The most obvious and a serious limitation in this study is
the short follow-up period. This was necessitated because
of resource limitations. The benefits of cognitive-behav-
ioural programmes are known to diminish over time [20]
and further trials will be required before it can be assumed
that this is a worthwhile treatment. In this study there was
little evidence of regression in the blood pressure
improvement between the first and second follow-ups but
a more realistic follow-up period would be five years. If
the medical benefits of taking part could be shown to be
sustained over time, this simple programme might save
many lives in China and possibly in other countries where
lifelong treatment with 'western' medicines is not an
option for the general population.
Another apparent limitation is that only around a third of
those who were invited agreed to take part (Figure 1). Of
Mean systolic BP over time by randomised group Figure 2
Mean systolic BP over time by randomised group.BMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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course this proportion might increase if the method was
known to be effective. From the demographic data it
seemed it might have been people with better health
behaviour who volunteered and self-evidently the people
who took part were interested in trying to self-manage
their blood pressure. Only 17% of the participants were
smokers, 50% lower than the prevalence rate in Shanghai
(36%) [27]. The fact that only a proportion of the popu-
lation want to actively manage their health does not mean
that this treatment should be ignored; if 30% of those in
Shanghai with hypertension agreed to take part this
would bring treatment to around 360,000 people.
One of the weaknesses of this and most other trials of cog-
nitive-behavioural treatments is that patients are not
blind to allocation and the control group may do worse
because they know that they have been denied a treatment
they were interested in. To try to minimise this problem,
in this study the control group patients were told that they
would receive the treatment when the research project was
finished; and there was no evidence that their blood pres-
sure went worse during the trial. It was also clear that their
blood pressure remained the same and that all of the
change observed was a reduction in the intervention
group's blood pressure.
Small groups may vary in effectiveness because it is
impossible to create the same circumstances for each
group. In this study, for example, a 'group facilitator' was
chosen by the principle investigator and that person's per-
sonality might have influenced the effectiveness of the
group. However statistical tests showed that this was not
the case and that results did not vary by group.
A potential complication in interpreting the results in this
study was the degree of self-medication with popular
herbal remedies or with western medicines. The effective-
ness of the herbal treatment is controversial [10,11]. Even
if we presumed the traditional medicine to be ineffective,
there was not an imbalance between the groups for that
factor. At baseline there was not a significant excess of
people in the intervention group taking western medicine;
and 4 months after the end of treatment there were also
no significance differences between the groups in the pro-
portions taking western drugs. The changes in BP may be
even more surprising because they were also accompanied
by a reduction in the use of medication, both Chinese and
western, in the intervention group and a very slight
increase in the controls.
Mean diastolic BP over time by randomised group Figure 3
Mean diastolic BP over time by randomised group.
Table 4: Drug taking status at the 2nd follow-up
Category Control group Intervention group
Patient s reducing the dose 10 23
Patients increasing the dose 6 2
Patient s taking same dose 54 45
χ2 = 7.94, P = 0.02BMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
Page 10 of 11
(page number not for citation purposes)
The study did not achieve the hoped for benefits of chang-
ing dietary behaviour and the level of urine sodium. How-
ever, the participants appeared to already have had a
reasonably good diet, and the urinary Na/K ratio was
quite low (median = 2.14 at baseline) as compared with
north China. Of the 52 centres in the Intersalt study, Tian-
jin, a city in north China, had the highest urinary Na/K
ratio reaching as high as 6.7 [28]. Their dietary pattern was
close to that recommended by the China Nutrition Soci-
ety [29]. Weight, blood total cholesterol and waist circum-
ference were all significantly reduced. The behaviour that
did change significantly was activity levels. People in the
intervention group were sedentary for less time and
expended about 1,000 MET minutes more activity a week.
Theoretically an increase in activity could be responsible
for all of these benefits including the reduction in total
cholesterol [30]. Applying certain psychological models,
such as goal setting, to self-management programmes
appears to be important elements for them to be success-
ful [6]. Setting realistic and graduated goals was used in
this study as a core behavioural change technique. Reach-
ing goals would give patients a sense of control over their
illness, which could lead to the setting of more rigorous
goals at the next level.
Delivering treatments in countries where primary care
services are not well developed is a challenge. In Shanghai
the club-based model provides a good platform for
chronic disease self-management, ensuring sustainability
and accessibility. The results of this study suggest that this
new approach could easily be integrated with the existing
local chronic disease management system. Many commu-
nity health services centres have already set up anti-hyper-
tensive clubs; and it may be the case that they could have
a more effective impact on hypertension if they adopted a
cognitive-behavioural approach, whereby patients are
engaged in practical exercises to change behaviour rather
than only attending public lectures. Tilanqiao Neighbour-
hood has a population of 104,745, and 54 residents' com-
mittees [31]. It is unlikely that that the Tilanqiao club
could provide help for all of the hypertensive patients in
the local community and the Community Health Services
Centre might consider setting up clubs at the residents'
committee level to allow greater access. Health cadres at
residents' committees could act as facilitators, and the
Community Health Services Centre as a coordinating cen-
tre.
Table 3: Outcomes at 1st and 2nd follow-ups by group
Blood Pressure Mean Mean difference (95% CI) P value
Intervention Control
Systolic BP (mm Hg) 1st follow-up 128.10 138.62 10.52 (7.75–13.28) <0.001
2nd follow-up 130.57 140.72 10.15 (7.25–13.05) <0.001
Diastolic BP (mm Hg) 1st follow-up 80.40 88.25 7.85 (5.98–9.72) <0.001
2nd follow-up 81.67 89.96 8.29 (6.71–9.88) <0.001
Total cholesterol (mmol/L) 1st follow-up 4.99 5.43 0.45 (0.24–0.65) <0.001
2nd follow-up 5.14 5.42 0.28 (0.06–0.49) 0.013
Urine Na/K ratio 1st follow-up 0.67 0.60 0.07 (-0.26–0.11) 0.445
2nd follow-up 0.70 0.52 0.19 (-0.03–0.41) 0.094
Waist circumference (cm) 1st follow-up 81.95 85.07 3.12 (2.36–3.89) <0.001
2nd follow-up 82.80 85.17 2.37 (1.56–3.18) <0.001
Body mass index (BMI) 1st follow-up 24.39 24.72 0.33 (0.06–0.60) 0.016
2nd follow-up 24.43 24.74 0.31 (0.00–0.62) 0.048
Physical activity 1st follow-up Sitting total minutes/week 1238.35 1757.01 518.65 (374.46–662.85) <0.001
Total physical activity (MET-minutes/week) 4572.94 3475.49 1097.45 (900.81–1294.10) <0.001
2nd follow-up Sitting total minutes/week 1531.25 1844.42 313.18 (143.94–482.42) <0.001
Total physical activity (MET-minutes/week) 4259.58 3239.43 1020.15 (786.24–1254.06) <0.001
Diet (daily intake) 1st follow-up Red meat (g) 59.10 57.63 1.47 (-2.47–5.41) 0.462
Vegetables (g) 325.20 320.96 4.24 (-2.21–10.69) 0.196
Fruits (g) 160.09 163.44 3.35 (-2.70–9.40) 0.276
2nd follow-up Red meat (g) 60.45 58.72 1.74 (-3.59–7.07) 0.520
Vegetables (g) 315.78 309.70 6.09 (-3.74–15.91) 0.223
Fruits (g) 155.69 161.33 5.64 (-2.97–14.24) 0.197
HRQOL SF12 1st follow-up Physical 47.72 43.44 4.28 (1.85–6.71) 0.001
Mental 56.48 52.66 3.83 (1.97–5.68) <0.001
2nd follow-up Physical 47.25 44.19 3.06 (0.72–5.40) 0.011
Mental 54.88 52.80 2.08 (0.12–4.04) 0.038BMC Cardiovascular Disorders 2008, 8:10 http://www.biomedcentral.com/1471-2261/8/10
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Conclusion
In Shanghai, a simple intervention of 8.5 hours' face-to-
face group contact and a self-help manual produced
improvement in lifestyle accompanied by clinically signif-
icant reductions in blood pressure in patients with mild-
to-moderate hypertension. Further research is required to
see if the benefits would persist long enough to have an
impact on the incidence of stroke and heart disease.
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